Last reviewed · How we verify
NCT04017988
Efficacy and Safety of Ethanol Extracts of Porphyra Tenera(PTE10) on Promotion of Immunity
NA trial testing Ethanol Extracts of Porphyra Tenera(PTE10) in Immunity in 120 participants. Status unknown.
30 April 2020
Quick facts
| Lead sponsor | Chonbuk National University Hospital |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | prevention |
| Enrollment | 120 |
| Start date | 13 June 2019 |
| Primary completion | 30 April 2020 |
| Estimated completion | 30 April 2020 |
| Sites | 1 location across South Korea |
Drugs / interventions tested
- Ethanol Extracts of Porphyra Tenera(PTE10)
- Placebo
Conditions studied
- Immunity — all drugs for Immunity →
Sponsor
Chonbuk National University Hospital
Who can join
50 and older, any sex, with Immunity. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study was conducted to investigate the efficacy and safety of ethanol extracts of Porphyra tenera(PTE10) on promotion of immunity
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Effects of <i>Porphyra tenera</i> Supplementation on the Immune System: A Randomized, Double-Blind, and Placebo-Controlled Clinical Trial.
Jung SJ, Jang HY, Jung ES, Noh SO, et al · · 2020 · cited 5× · PMID 32498269 · DOI 10.3390/nu12061642
Verify or expand the search:
- PubMed search for NCT04017988
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Immunity
Currently open trials in the same condition.
- NCT07341750 — Effects of Bacillus Coagulans SNZ 1969 on Immune Health in Healthy School-aged Children · NA · recruiting
- NCT06724185 — Effects of LP28 on Immunity Enhancement in the Elderly · NA · recruiting
Other Chonbuk National University Hospital trials
Trials by the same sponsor.
- NCT05324800 — the Efficacy and Safety of Curcuma Longa Extract Mixture on Immune Enhancement · NA · unknown
- NCT05450939 — Characteristics of Signal Intensity Gradient in Subarachnoid Hemorrhage After Aneurysmal Rupture · unknown
- NCT05190237 — the Efficacy and Safety of Fermented Soybean(Doenjang Powder) on Intestinal Microflora and Immune Enhancement. · NA · completed
- NCT05495191 — Signal Intensity Gradient in Cerebral Arteries · completed
- NCT04940910 — The Efficacy and Safety of Black Rice Bran Extract on Immune Enhancement · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04017988 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Chonbuk National University Hospital
- Last refreshed: 12 July 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04017988.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing